60 Degrees Pharmaceuticals, Inc.
SXTP
$2.82
-$0.09-3.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 791.50K | 670.50K | 451.80K | 430.50K | 367.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 791.50K | 670.50K | 451.80K | 430.50K | 367.40K |
| Cost of Revenue | 3.69M | 3.61M | 4.39M | 3.67M | 872.40K |
| Gross Profit | -2.90M | -2.94M | -3.93M | -3.24M | -505.00K |
| SG&A Expenses | 5.64M | 5.03M | 5.11M | 5.21M | 4.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.09M | 10.40M | 10.00M | 9.38M | 5.91M |
| Operating Income | -10.29M | -9.73M | -9.54M | -8.95M | -5.55M |
| Income Before Tax | -10.26M | -7.96M | -7.95M | -1.62M | -788.10K |
| Income Tax Expenses | 300.00 | 300.00 | 900.00 | 700.00 | 400.00 |
| Earnings from Continuing Operations | -10.26 | -7.96 | -7.95 | -1.62 | -0.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.90K | 8.60K | 38.60K | 47.60K | 53.10K |
| Net Income | -10.25M | -7.95M | -7.91M | -1.57M | -735.20K |
| EBIT | -10.29M | -9.73M | -9.54M | -8.95M | -5.55M |
| EBITDA | -10.24M | -9.68M | -9.50M | -8.90M | -5.50M |
| EPS Basic | -29.63 | -26.22 | -45.92 | 4.28 | -58.76 |
| Normalized Basic EPS | -17.86 | -15.34 | -26.53 | -34.40 | -57.31 |
| EPS Diluted | -29.63 | -26.22 | -45.92 | 4.28 | -58.76 |
| Normalized Diluted EPS | -17.86 | -15.34 | -26.53 | -34.40 | -57.31 |
| Average Basic Shares Outstanding | 2.93M | 1.82M | 957.40K | 558.40K | 395.00K |
| Average Diluted Shares Outstanding | 2.93M | 1.82M | 957.40K | 558.40K | 395.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |